Product NDC: | 0076-0901 |
Proprietary Name: | Hyophen |
Non Proprietary Name: | Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
Active Ingredient(s): | 9; .12; 81.6; 10.8; 36.2 mg/1; mg/1; mg/1; mg/1; mg/1 & nbsp; Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0076-0901 |
Labeler Name: | Star Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20100921 |
Package NDC: | 0076-0901-01 |
Package Description: | 100 TABLET in 1 BOTTLE (0076-0901-01) |
NDC Code | 0076-0901-01 |
Proprietary Name | Hyophen |
Package Description | 100 TABLET in 1 BOTTLE (0076-0901-01) |
Product NDC | 0076-0901 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100921 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Star Pharmaceuticals, LLC |
Substance Name | BENZOIC ACID; HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE |
Strength Number | 9; .12; 81.6; 10.8; 36.2 |
Strength Unit | mg/1; mg/1; mg/1; mg/1; mg/1 |
Pharmaceutical Classes | Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC] |